5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | BUY | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.91▲ | 1.91▲ | 1.89▲ | 1.96▼ | 1.99▼ |
MA10 | 1.91▼ | 1.88▲ | 1.89▲ | 2.11▼ | 2.21▼ |
MA20 | 1.91▼ | 1.89▲ | 1.95▼ | 1.98▼ | 3.08▼ |
MA50 | 1.88▲ | 1.98▼ | 2.07▼ | 2.44▼ | 6.58▼ |
MA100 | 1.89▲ | 2.08▼ | 2.06▼ | 3.41▼ | 7.54▼ |
MA200 | 1.95▼ | 2.04▼ | 1.91▼ | 6.13▼ | 9.93▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.002▼ | 0.010▲ | 0.003▲ | 0.021▲ | 0.098▲ |
RSI | 55.184▲ | 47.114▼ | 40.279▼ | 42.226▼ | 30.127▼ |
STOCH | 16.111▼ | 75.661 | 38.534 | 22.978 | 14.973▼ |
WILL %R | -66.667 | -18.182▲ | -53.846 | -79.856▼ | -87.019▼ |
CCI | -37.838 | 104.368▲ | -12.140 | -79.667 | -67.253 |
Saturday, June 21, 2025 11:33 PM
IOVA FRAUD ALERT: Iovance Biotherapeutics Investors are Reminded of Ongoing Securities Fraud Class Action — Contact BFA Law by July 14 Legal Deadline (NASDAQ:IOVA) ...
|
Saturday, June 21, 2025 11:33 PM
NEW YORK, June 22, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Iovance Biotherapeutics, Inc. (NASDAQ ...
|
Saturday, June 14, 2025 05:12 AM
Iovance faces major setbacks with AMTAGVI's weak launch, cash burn, and scalability issues despite scientific progress. Find out why IOVA stock is a sell.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
24/06/25 | 1.87 | 1.93 | 1.82 | 1.91 | 3,060,207 |
23/06/25 | 1.94 | 1.97 | 1.84 | 1.85 | 9,067,700 |
20/06/25 | 2.07 | 2.09 | 1.97 | 1.98 | 11,217,300 |
18/06/25 | 2.00 | 2.10 | 1.95 | 2.04 | 8,357,100 |
17/06/25 | 2.05 | 2.13 | 2.01 | 2.02 | 7,857,100 |
16/06/25 | 2.20 | 2.22 | 2.011 | 2.08 | 12,600,557 |
13/06/25 | 2.23 | 2.31 | 2.20 | 2.24 | 8,786,100 |
12/06/25 | 2.20 | 2.32 | 2.15 | 2.31 | 13,544,000 |
11/06/25 | 2.42 | 2.43 | 2.21 | 2.24 | 17,192,800 |
10/06/25 | 2.205 | 2.465 | 2.205 | 2.395 | 20,109,230 |
|
|
||||
|
|
||||
|
|